|Articles|November 15, 2021
Pharmacy Clinical Pearl of the Day: Liver Cancer
Author(s)Saro Arakelians, PharmD
Risk factors for liver cancer include chronic infection with hepatitis B or hepatitis C virus, cirrhosis, diabetes, and non-alcoholic fatty liver disease.
Advertisement
Clinical Pearl of the Day: Liver Cancer
Liver cancer begins in the cells of the liver.
Insight:
- The most common type of liver cancer is hepatocellular carcinoma, which begins in the main type of liver cell (hepatocyte).
- Some of the symptoms include weight loss, appetite loss, upper abdominal pain, vomiting, general weakness, abdominal swelling, white and chalky stool.
- Risk factors include chronic infection with hepatitis B or hepatitis C virus, cirrhosis, inherited liver diseases, diabetes, non-alcoholic fatty liver disease, and alcohol consumption.
- Diagnosis includes blood test, imaging tests, and removing a sample of the liver for biopsy.
- Treatment includes surgery, targeted drug therapy, immunotherapy, chemotherapy, and supportive care.
- Some of the chemotherapy drugs include gemcitabine (Gemzar), oxaliplatin (Eloxatin), cisplatin, doxorubicin (pegylated liposomal doxorubicin), 5-fluorouracil (5-FU), capecitabine (Xeloda), and mitoxantrone (Novantrone).
- Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
FDA Approves Gepotidacin for Urogenital Gonorrhea in Adult and Pediatric Patients
3
Emerging Data from the DESTINY-Breast Trials Signal Shift in Standards of Care for HER2-Positive Breast Cancer
4
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
5
